Anemia in patients with tumors of the female reproductive system

Objective: to assess the efficacy of Sideral forte (combination of sucrosomial iron and vitamin C) in the treatment of iron deficiency anemia in patients with tumors of the female reproductive system.Materials and methods. The study included 35 patients with benign tumors of the female reproductive...

Full description

Saved in:
Bibliographic Details
Main Authors: A. G. Kedrova, T. A. Greyan, N. S. Vanke, S. E. Krasilnikovт
Format: Article
Language:Russian
Published: ABV-press 2019-11-01
Series:Опухоли женской репродуктивной системы
Subjects:
Online Access:https://ojrs.abvpress.ru/ojrs/article/view/660
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839570930432475136
author A. G. Kedrova
T. A. Greyan
N. S. Vanke
S. E. Krasilnikovт
author_facet A. G. Kedrova
T. A. Greyan
N. S. Vanke
S. E. Krasilnikovт
author_sort A. G. Kedrova
collection DOAJ
description Objective: to assess the efficacy of Sideral forte (combination of sucrosomial iron and vitamin C) in the treatment of iron deficiency anemia in patients with tumors of the female reproductive system.Materials and methods. The study included 35 patients with benign tumors of the female reproductive system and 27 patients with cancer; all of them were also diagnosed with grade I iron deficiency anemia. The duration of therapy with Sideral forte at a dose of 1 capsule per day varied between 30 and 60 days. We evaluated frequency and intensity of clinical and hematological response to treatment, as well as drug tolerability.Results. Therapy with Sideral forte ensured improvement of blood parameters in both patient groups. All participants received the drug during 8 weeks; it was well tolerated, demonstrated no side effects, and did not cause gastrointestinal disorders. The increase in the level of hemoglobin was observed in both groups; however, cancer patients had less pronounced dynamics.Conclusions. Sideral forte is an effective oral drug that can be used for the treatment of iron deficiency anemia in patients with tumors of the female reproductive system.
format Article
id doaj-art-81c77a72e26f4a2ca4fb5f85fd6e26f8
institution Matheson Library
issn 1994-4098
1999-8627
language Russian
publishDate 2019-11-01
publisher ABV-press
record_format Article
series Опухоли женской репродуктивной системы
spelling doaj-art-81c77a72e26f4a2ca4fb5f85fd6e26f82025-08-04T14:33:41ZrusABV-pressОпухоли женской репродуктивной системы1994-40981999-86272019-11-01153313610.17650/1994-4098-2019-15-3-31-36620Anemia in patients with tumors of the female reproductive systemA. G. Kedrova0T. A. Greyan1N. S. Vanke2S. E. Krasilnikovт3Federal Scientific and Clinical Center for Specialized Medical Assistance and Medical Technologies of the Federal Medical Biological Agency of Russia; Academy of Postgraduate Education under the Federal Scientific and Clinical Center for Specialized Medical Assistance and Medical Technologies of the Federal Medical Biological Agency of RussiaAcademy of Postgraduate Education under the Federal Scientific and Clinical Center for Specialized Medical Assistance and Medical Technologies of the Federal Medical Biological Agency of RussiaFederal Scientific and Clinical Center for Specialized Medical Assistance and Medical Technologies of the Federal Medical Biological Agency of Russia; Academy of Postgraduate Education under the Federal Scientific and Clinical Center for Specialized Medical Assistance and Medical Technologies of the Federal Medical Biological Agency of RussiaNovosibirsk Regional Clinical Narcology DispensaryObjective: to assess the efficacy of Sideral forte (combination of sucrosomial iron and vitamin C) in the treatment of iron deficiency anemia in patients with tumors of the female reproductive system.Materials and methods. The study included 35 patients with benign tumors of the female reproductive system and 27 patients with cancer; all of them were also diagnosed with grade I iron deficiency anemia. The duration of therapy with Sideral forte at a dose of 1 capsule per day varied between 30 and 60 days. We evaluated frequency and intensity of clinical and hematological response to treatment, as well as drug tolerability.Results. Therapy with Sideral forte ensured improvement of blood parameters in both patient groups. All participants received the drug during 8 weeks; it was well tolerated, demonstrated no side effects, and did not cause gastrointestinal disorders. The increase in the level of hemoglobin was observed in both groups; however, cancer patients had less pronounced dynamics.Conclusions. Sideral forte is an effective oral drug that can be used for the treatment of iron deficiency anemia in patients with tumors of the female reproductive system.https://ojrs.abvpress.ru/ojrs/article/view/660anemic syndromeiron deficiency anemiauterine tumorsovarian tumors
spellingShingle A. G. Kedrova
T. A. Greyan
N. S. Vanke
S. E. Krasilnikovт
Anemia in patients with tumors of the female reproductive system
Опухоли женской репродуктивной системы
anemic syndrome
iron deficiency anemia
uterine tumors
ovarian tumors
title Anemia in patients with tumors of the female reproductive system
title_full Anemia in patients with tumors of the female reproductive system
title_fullStr Anemia in patients with tumors of the female reproductive system
title_full_unstemmed Anemia in patients with tumors of the female reproductive system
title_short Anemia in patients with tumors of the female reproductive system
title_sort anemia in patients with tumors of the female reproductive system
topic anemic syndrome
iron deficiency anemia
uterine tumors
ovarian tumors
url https://ojrs.abvpress.ru/ojrs/article/view/660
work_keys_str_mv AT agkedrova anemiainpatientswithtumorsofthefemalereproductivesystem
AT tagreyan anemiainpatientswithtumorsofthefemalereproductivesystem
AT nsvanke anemiainpatientswithtumorsofthefemalereproductivesystem
AT sekrasilnikovt anemiainpatientswithtumorsofthefemalereproductivesystem